Hims Hers Really Growth Stock Faces Reality Check Now
Hims & Hers Health shifts to selling branded Wegovy and Ozempic after a settlement with Novo Nordisk, reversing regul...
Flat index levels can mask underlying shifts among components; still, broader market movements may occur through price changes in parts.
28,641 articlesHims & Hers Health shifts to selling branded Wegovy and Ozempic after a settlement with Novo Nordisk, reversing regul...
A May 2026 industry survey shows firms narrowing recruiting to a curated roster of schools and weighing GPA more heav...
Elon Musk’s clash with OpenAI doubles as a bid to launch xAI, with Tesla financing and strategic partnerships setting...
A universal technical institute director recently sold 10,000 shares, sparking questions about what it means for UTI ...
Dell Technologies rides an AI demand wave after strong quarterly results, fueling debate about whether the stock can ...
New surveys in 2026 reveal mounting retirement worries: only about a quarter of Americans feel prepared, while the ty...
Ripple’s latest briefing argues passive Zcash holders remain protected if they did not trigger the exploit, even as m...
Rechat expands its platform to let brokerages, teams, and vendors build branded apps atop its real estate OS. The fea...
A $20 million unrestricted gift to Santa Barbara City College from Mackenzie Scott is under investigation after the b...
Bitcoin outpaced Solana over the past five years on a total-return basis, but SOL delivered sharper upside during tec...
Sandisk leads the 2026 market rally, with outsized gains that eclipse every other S&P 500 stock. Analysts weigh how l...
A top wall street billionaire turned investor stretched a routine intro with a media cofounder into a full-day sessio...